ArticleBMC public health2014
Economic burden of seasonal influenza B in France during winter 2010-2011.
Article in BMC public health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 3 syntheses or guidelines pooled it, 23 citations in OpenAlex.
- The economic burden of influenza among adults aged 18 to 64: A systematic literature review.Influenza and other respiratory viruses · 2022Pooled it
- Pooled it
- Health care costs of influenza-related episodes in high income countries: A systematic review.PloS one · 2018Pooled it
- Cost-Effectiveness Analysis of Expanding Influenza Vaccination to Adults Aged 50 and Over in France.Infectious diseases and therapy · 2025Article
- Caregiver Burden among Patients with Influenza or Influenza-like Illness (ILI): A Systematic Literature Review.Healthcare (Basel, Switzerland) · 2024Review
- Seasonal influenza in children: Costs for the health system and society in Europe.Influenza and other respiratory viruses · 2022Review
- Economic costs of severe seasonal influenza in Colombia, 2017-2019: A multi-center analysis.PloS one · 2022Article
- [Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz TetraJournal of preventive medicine and hygiene · 2021Article
- Epidemiology of influenza B in Australia: 2001-2014 influenza seasons.Influenza and other respiratory viruses · 2017Article
- Public health and economic impact of seasonal influenza vaccination with quadrivalent influenza vaccines compared to trivalent influenza vaccines in Europe.Human vaccines & immunotherapeutics · 2016Article
- Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.Paediatric drugs · 2016Article
- Impact of Influenza on Outpatient Visits, Hospitalizations, and Deaths by Using a Time Series Poisson Generalized Additive Model.PloS one · 2016Article
- Evolution of Influenza B Virus in Kuala Lumpur, Malaysia, between 1995 and 2008.Journal of virology · 2015Article
- Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003-2013.BMC infectious diseases · 2015Article
- Investigating the airborne transmission pathway - different approaches with the same objectives.Indoor air · 2015Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn France, 2-15% of the population is affected annually by influenza, which causes significant socioeconomic disruption. Nevertheless, despite its importance for policy makers, few published studies have evaluated the impact of influenza B. Therefore, we assessed the costs associated with influenza B during 2010-2011 in France.
methodsCases of lab-confirmed influenza B were analyzed as part of the Influenza B in General Practice Study. Cost calculations were based on micro-costing methods according to the French Health Insurance (FHI) perspective (in Euros, 2011). Costs were compared between age groups using the Kruskal-Wallis test, and when significant, by multiple comparisons based on rank. Moreover, uncertainties were assessed using one-way sensitivity and probabilistic analyses. Overall economic burden was estimated by multiplying cost per patient, flu attack rate, and the French population.
resultsA total of 201 patients were included in the study. We found that the mean cost associated with Influenza B was 72€ (SD: 205) per patient: 70€ (SD: 262) for younger children, 50€ (SD: 195) for older children, 126€ (SD: 180) for adults, and 42€ (SD: 18) for elderly. Thus, we observed significantly different costs between the distinct age groups (p<0.0001). Finally, the economic burden of influenza B for the FHI was estimated to be 145 million Euros (95% CI: 88-201).
conclusionsOur findings highlight the important impact of influenza B and encourage further investigation on policy regarding vaccination strategies in France.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.